Guiding Icarus (eBook)

Merging Bioethics with Corporate Interests

(Autor)

eBook Download: PDF
2003 | 1. Auflage
296 Seiten
John Wiley & Sons (Verlag)
978-0-471-46132-6 (ISBN)

Lese- und Medienproben

Guiding Icarus - Rahul K. Dhanda
Systemvoraussetzungen
25,99 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
"There is a palpable need for business to explore the issues Dhanda raises. Guiding Icarus offers a flight plan."

-from the Foreword by Philip R. Reilly

Guiding ICARUS

Merging Bioethics with Corporate Interests

Rahul K. Dhanda

While bioethicists may enjoy the most thorough appreciation of both the promise and perils of new biotechnologies, international corporations are in fact the entities generating these technologies and determining their application. An industry insider versed in the language of bioethics, Rahul Dhanda offers in Guiding Icarus: Merging Bioethics with Corporate Interests a Rosetta stone to these two camps, explaining why each needs the other, why their disparate concerns often cohere, and why an ethical business is likely a successful one.

The author develops a dialogue between bioethics and corporate interests by examining case studies of several hot-button issues, including:

* Genetically modified foods

* DNA data banking

* Personalized medicine

* Stem cell research

In each instance he provides a treatment of the particular science under consideration, a list of the benefits of the technology, a description of the ethical issues involved, an account of past industry response, and recommendations for future action. Given the expansive nature of biotechnology, ramifications in the pharmaceutical and agricultural industries are covered in depth as well. The book also features a Foreword by world-renowned bioethicist and biotechnology CEO Philip R. Reilly as well as a step-by-step discussion of the components of business and bioethical issues.

Written for a general audience, Guiding Icarus will be particularly useful to biotechnologists, regulatory affairs managers, and corporate officers of biotechnology firms, as well as bioethicists in the academic community. Dhanda's peerless text provides a unique tool for understanding and addressing the ethical dilemmas confronting society in the 21st century.

PHIL LEMPERT has gained wide acclaim for his marketing savvy and broad experience in the food and marketing worlds. A distinguished speaker, he has addressed more than 600,000 people in the past decade alone. Known as the Supermarket Guru, he is widely respected for his ability to predict and analyze trends. He is the food editor and correspondent for NBC News's Today show, host of the nationally syndicated radio show "Shopping Smart," and a correspondent for BBC Radio 5 Live and Public Radio's KCRW-FM. Lempert has been a columnist for the Chicago Tribune and the Los Angeles Times and is currently the editor of The Lempert Report and Supermarketguru.com, one of the leading Internet resources for food, health, and trend information.

Foreword.

Preface.

Acknowledgments.

Introduction.

Genetically Modified Foods.

DNA Data Banking.

Personalized Medicine.

Stem Cells.

Conclusion.

Glossary.

Suggested Reading.

Index.

"...particularly useful to corporate biotech managers due to Dhanda's explanation of the issues and suggestions on how to engage the public...inherent value in this discourse is how Dhanda explains how an ethical biotech business is likely to be a successful one." (Genomics & Proteomics, May 2002)

"useful to biotechnologists, regulatory affairs managers, and corporate officers of biotech firms, as well as bioethicists..." (Genetic Engineering News, July 2002)

"...if you read The Economist you'll doubtless find this of interest..." (Focus, August 2002)

"...offers an insider's view on why a bridge is needed to merge bioethics with corporate needs...written for the general audience...is especially useful to biotechnologists, regulatory affairs managers, and corporate officers of biotech firms, as well as bioethicists..." (Genetic Engineering News, Vol. 22, No. 13, July 2002)

"...lays out a blueprint for executives...focusing on four subjects..." (HBS (Harvard Business School) Working Knowledge, July 2002)

"This book should stimulate much useful discussion in the biotechnology industry...the author should be congratulated." (Nature Biotechnology, August 1, 2002)

"Guiding Icarus [...] is timely and well written. I particularly
enjoyed reading the chapters on Personalized Medicine and Stem
Cells. People new to these "hot" topics will find [the]
descriptions very informative." --Milo Gibaldi, Department of
Pharmaceutics, University of Washington School of Pharmacy

A Featured Book Recommendation with a link to buy the book on
Harvard Business School's website: "...lays out a blueprint for
executives...focusing on four subjects..." --HBS (Harvard Business
School) Working Knowledge, July 2002

Erscheint lt. Verlag 14.4.2003
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Medizinethik
Studium Querschnittsbereiche Geschichte / Ethik der Medizin
Naturwissenschaften Biologie Mikrobiologie / Immunologie
Technik Umwelttechnik / Biotechnologie
Wirtschaft Betriebswirtschaft / Management Unternehmensführung / Management
Schlagworte Biotech & Gene Technology • Biotechnologie i. d. Biowissenschaften • Biotechnologie- u. Gentechnikrecht • Biotechnology • Biowissenschaften • Business & Management • Business & Management Special Topics • Law • Life Sciences • Rechtswissenschaft • Spezialthemen Wirtschaft u. Management • Wirtschaft u. Management
ISBN-10 0-471-46132-6 / 0471461326
ISBN-13 978-0-471-46132-6 / 9780471461326
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Physician Entrepreneurs Who Live Life and Practice Medicine on Their …

von Nneka Unachukwu

eBook Download (2023)
Entremd Publishing (Verlag)
10,99
A Discovery of Meaning in the Coronavirus Pandemic and its …

von Barbara E. Hort

eBook Download (2023)
Distributed By Ingram Spark (Verlag)
10,99

von Alec Riley; Michael Crane; Bernard de Broglio

eBook Download (2023)
Little Gully Publishing (Verlag)
10,99